← Back to Search

Community Health Worker Support for Pediatric Type 1 Diabetes

N/A
Waitlist Available
Led By Colin P Hawkes, MD PhD
Research Sponsored by Children's Hospital of Philadelphia
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be younger than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 1.5 years
Awards & highlights
No Placebo-Only Group

Summary

This trial is testing whether adding a Community Health Worker to the care team of children with newly diagnosed type 1 diabetes improves diabetes control, as well as other outcomes.

Who is the study for?
This trial is for children under 17 with new Type 1 Diabetes, covered by government insurance, living within a 30-minute drive of CHOP in Pennsylvania. They must be autoantibody positive and plan to complete the 'Type 1 Year 1' program at CHOP. Excluded are those who are autoantibody negative, non-English speaking, or have certain insurances.
What is being tested?
The study tests if adding a Community Health Worker (CHW) to the diabetes care team helps manage children's newly diagnosed Type 1 Diabetes better. It looks at diabetes control, psychosocial outcomes, healthcare use, and costs.
What are the potential side effects?
Since this trial involves adding a support role rather than a medical treatment, traditional side effects like you'd see with medications aren't expected. However, there may be indirect impacts on family dynamics or stress levels.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~1.5 years
This trial's timeline: 3 weeks for screening, Varies for treatment, and 1.5 years for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Hemoglobin A1c
Secondary study objectives
Caregiver Depression
Emergency Department utilization
Healthcare costs
+6 more

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Community Health Worker GroupExperimental Treatment1 Intervention
Patients are assigned a community health worker for the first year in addition to standard diabetes care. They do not receive a community health worker for the second year of the study.
Group II: Standard Diabetes Care GroupActive Control1 Intervention
Patients receive standard diabetes care.

Find a Location

Who is running the clinical trial?

Children's Hospital of PhiladelphiaLead Sponsor
729 Previous Clinical Trials
8,470,234 Total Patients Enrolled
5 Trials studying Diabetes
240 Patients Enrolled for Diabetes
Leonard Davis Institute of Health EconomicsUNKNOWN
3 Previous Clinical Trials
401 Total Patients Enrolled
Colin P Hawkes, MD PhDPrincipal InvestigatorChildren's Hospital of Philadelphia
1 Previous Clinical Trials
84 Total Patients Enrolled

Media Library

Community Health Worker added to diabetes team Clinical Trial Eligibility Overview. Trial Name: NCT04238949 — N/A
Diabetes Research Study Groups: Standard Diabetes Care Group, Community Health Worker Group
Diabetes Clinical Trial 2023: Community Health Worker added to diabetes team Highlights & Side Effects. Trial Name: NCT04238949 — N/A
Community Health Worker added to diabetes team 2023 Treatment Timeline for Medical Study. Trial Name: NCT04238949 — N/A
~0 spots leftby Jan 2025